JPWO2023118557A5 - - Google Patents
Info
- Publication number
- JPWO2023118557A5 JPWO2023118557A5 JP2024537407A JP2024537407A JPWO2023118557A5 JP WO2023118557 A5 JPWO2023118557 A5 JP WO2023118557A5 JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024537407 A JP2024537407 A JP 2024537407A JP WO2023118557 A5 JPWO2023118557 A5 JP WO2023118557A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- injectable pharmaceutical
- compound
- formula
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217704.2 | 2021-12-24 | ||
| EP21217704 | 2021-12-24 | ||
| PCT/EP2022/087700 WO2023118557A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544415A JP2024544415A (ja) | 2024-11-29 |
| JPWO2023118557A5 true JPWO2023118557A5 (enExample) | 2026-01-05 |
Family
ID=79601675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537407A Pending JP2024544415A (ja) | 2021-12-24 | 2022-12-23 | 動物における呼吸器疾患の治療のための注射用医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057790A1 (enExample) |
| EP (1) | EP4452226A1 (enExample) |
| JP (1) | JP2024544415A (enExample) |
| CN (1) | CN118632684A (enExample) |
| AR (1) | AR128074A1 (enExample) |
| AU (1) | AU2022420882A1 (enExample) |
| CA (1) | CA3242451A1 (enExample) |
| MX (1) | MX2024007862A (enExample) |
| WO (1) | WO2023118557A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4208157A1 (en) | 2020-09-04 | 2023-07-12 | Elanco Us Inc. | Palatable formulations |
| WO2025133088A1 (en) | 2023-12-21 | 2025-06-26 | Intervet International B.V. | Crystalline forms of(s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts |
| WO2025133098A2 (en) | 2023-12-21 | 2025-06-26 | Intervet International B.V. | Processes to make crystalline forms of (s)-n-(3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4- ((4-(((2-methoxyethyl)amino)methyl)phenyl)ethynyl)benzamide salts |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| JP7082445B2 (ja) | 2016-12-23 | 2022-06-08 | インターベット インターナショナル ベー． フェー． | ウシ又はブタの呼吸器疾患を治療するための化合物 |
-
2022
- 2022-12-22 AR ARP220103558A patent/AR128074A1/es unknown
- 2022-12-23 AU AU2022420882A patent/AU2022420882A1/en active Pending
- 2022-12-23 US US18/721,947 patent/US20250057790A1/en active Pending
- 2022-12-23 WO PCT/EP2022/087700 patent/WO2023118557A1/en not_active Ceased
- 2022-12-23 CA CA3242451A patent/CA3242451A1/en active Pending
- 2022-12-23 MX MX2024007862A patent/MX2024007862A/es unknown
- 2022-12-23 CN CN202280085114.3A patent/CN118632684A/zh active Pending
- 2022-12-23 EP EP22844124.2A patent/EP4452226A1/en active Pending
- 2022-12-23 JP JP2024537407A patent/JP2024544415A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100752836B1 (ko) | 분산성 약학 조성물 | |
| CA1339085C (fr) | Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires | |
| CN1239427A (zh) | Mupirocin在制备用于治疗与病原生物体鼻咽建群有关的细菌感染的药物中的应用 | |
| JP2006328089A (ja) | 安定な局所レチノイド組成物 | |
| AU2003233653A1 (en) | Compositions and method for transmucosal drug delivery and cryoprotection | |
| RU93004907A (ru) | Производные гидроксамовой кислоты и n-гидроксимочевины. способ их получения фармацевтическая композиция и способ лечения | |
| JP2001513550A5 (enExample) | ||
| JP2015508068A5 (enExample) | ||
| BG60450B2 (bg) | Фармацевтичен състав | |
| US12357655B2 (en) | Polyglutamic acid compositions and methods of using | |
| MXPA06012655A (es) | Preparaciones topicas que contienen ambroxol. | |
| JP2024544415A (ja) | 動物における呼吸器疾患の治療のための注射用医薬組成物 | |
| JP2025061451A5 (enExample) | ||
| RU96119364A (ru) | Производная бензамида, композиции, содержащие упомянутую производную, и их применение | |
| CA2583876A1 (en) | A transmucosal veterinary composition comprising detomidine | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| RU2002103862A (ru) | Новые аминобензофеноны | |
| JPWO2023118557A5 (enExample) | ||
| EP4126057B1 (en) | Composition having improved voluntary acceptance | |
| JP2008532967A5 (enExample) | ||
| JP2009523803A (ja) | トリアゾール化合物による炎症性疾患の処置 | |
| RU2008147790A (ru) | Фармацевтическая композиция на основе тилорона местного и наружного применения для лечения гнойно-деструктивных поражений слизистой и кожи, общесистемных заболеваний при иммунодефицитных состояниях | |
| RU2014141341A (ru) | Паралитический яд моллюсков | |
| JP6128572B2 (ja) | ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸を含有する水性液体組成物 | |
| RU2024120685A (ru) | Инъекционная фармацевтическая композиция для лечения респираторных заболеваний у животных |